The development of novel LTA4H modulators to selectively target LTB4 generation

Low, Caroline M, Akthar, Samia, Patel, Dhiren F, Löser, Stephen, Wong, Chi-Tung Wong, Jackson, Patricia L, Blalock, J Edwin, Hare, Stephen A, Lloyd, Clare M and Snelgrove, Robert J (2017) The development of novel LTA4H modulators to selectively target LTB4 generation. Scientific Reports, 7. ISSN 2045-2322

[img] PDF - Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

The pro-inflammatory mediator leukotriene B4 (LTB4) is implicated in the pathologies of an array of diseases and thus represents an attractive therapeutic target. The enzyme leukotriene A4 hydrolase (LTA4H) catalyses the distal step in LTB4 synthesis and hence inhibitors of this enzyme have been actively pursued. Despite potent LTA4H inhibitors entering clinical trials all have failed to show efficacy. We recently identified a secondary anti-inflammatory role for LTA4H in degrading the neutrophil chemoattractant Pro-Gly-Pro (PGP) and rationalized that the failure of conventional LTA4H inhibitors may be that they inadvertently prevented PGP degradation. We demonstrate that these inhibitors do indeed fail to discriminate between the dual activities of LTA4H, and enable PGP accumulation in mice. Accordingly, we have developed novel compounds that potently inhibit LTB4 generation whilst leaving PGP degradation unperturbed. These novel compounds could represent a safer and superior class of LTA4H inhibitors for translation into the clinic.

Item Type: Article
Schools and Departments: School of Life Sciences > Biochemistry
Depositing User: Stephen Hare
Date Deposited: 21 Sep 2017 15:38
Last Modified: 09 Feb 2018 14:44
URI: http://sro.sussex.ac.uk/id/eprint/70271

View download statistics for this item

📧 Request an update